$217.95
-0.11-0.05%
At close: -
$217.95
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
West Pharmaceutical Servs Stock Guidance | NYSE:WST | Benzinga
West Pharmaceutical Servs issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/24/2025 | WST | West Pharmaceutical Servs | FY | 2025 | $6.15 | $6.35 | $6.19 | $2.94B | $2.98B | $2.90B | Get Alert |
| 02/13/2025 | WST | West Pharmaceutical Servs | FY | 2025 | $6.00 | $6.20 | $7.43 | $2.88B | $2.90B | $3.04B | Get Alert |
| 10/24/2024 | WST | West Pharmaceutical Servs | FY | 2024 | $6.55 | $6.75 | $6.51 | $2.88B | $2.90B | $2.87B | Get Alert |
| 07/25/2024 | WST | West Pharmaceutical Servs | FY | 2024 | $6.35 | $6.65 | $7.74 | $2.87B | $2.90B | $3.01B | Get Alert |
| 04/25/2024 | WST | West Pharmaceutical Servs | FY | 2024 | $7.63 | $7.88 | $7.62 | $3.00B | $3.02B | $3.01B | Get Alert |
| 02/15/2024 | WST | West Pharmaceutical Servs | FY | 2024 | $7.50 | $7.75 | $8.76 | $3.00B | $3.02B | $3.21B | Get Alert |
| 10/26/2023 | WST | West Pharmaceutical Servs | FY | 2023 | $7.95 | $8.00 | $7.85 | $2.95B | $2.96B | $2.99B | Get Alert |
| 07/27/2023 | WST | West Pharmaceutical Servs | FY | 2023 | $7.65 | $7.80 | $7.71 | $2.97B | $3.00B | $2.98B | Get Alert |
| 04/27/2023 | WST | West Pharmaceutical Servs | FY | 2023 | $7.50 | $7.65 | $7.42 | $2.96B | $2.99B | $2.96B | Get Alert |
| 02/16/2023 | WST | West Pharmaceutical Servs | FY | 2023 | $7.25 | $7.40 | $7.27 | $2.94B | $2.96B | $2.87B | Get Alert |
| 10/27/2022 | WST | West Pharmaceutical Servs | FY | 2022 | $8.15 | $8.20 | $9.07 | $2.83B | $2.84B | $2.98B | Get Alert |
| 07/28/2022 | WST | West Pharmaceutical Servs | FY | 2022 | $9.00 | $9.15 | $9.32 | $2.95B | $2.98B | $3.05B | Get Alert |
| 04/28/2022 | WST | West Pharmaceutical Servs | FY | 2022 | $9.30 | $9.45 | $9.28 | $3.05B | $3.08B | $3.07B | Get Alert |
| 02/17/2022 | WST | West Pharmaceutical Servs | FY | 2022 | $9.20 | $9.35 | $9.06 | $3.05B | $3.08B | $3.07B | Get Alert |
| 10/28/2021 | WST | West Pharmaceutical Servs | FY | 2021 | $8.40 | $8.50 | $8.21 | $2.80B | $2.81B | $2.80B | Get Alert |
| 07/29/2021 | WST | West Pharmaceutical Servs | FY | 2021 | $8.05 | $8.20 | $7.14 | $2.76B | $2.79B | $2.68B | Get Alert |
| 04/29/2021 | WST | West Pharmaceutical Servs | FY | 2021 | $6.95 | $7.10 | $6.15 | $2.63B | $2.65B | $2.58B | Get Alert |
| 02/18/2021 | WST | West Pharmaceutical Servs | FY | 2021 | $6.00 | $6.15 | $5.12 | $2.50B | $2.52B | $2.35B | Get Alert |
| 10/22/2020 | WST | West Pharmaceutical Servs | FY | 2020 | $4.50 | $4.55 | $4.25 | $2.10B | $2.11B | $2.05B | Get Alert |
FAQ
What is the most recent guidance for West Pharmaceutical Servs (WST)?
The most recent guidance for West Pharmaceutical Servs (WST) was reported on April 24, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $6.15 to $6.35, compared to the estimated EPS of $6.19. Additionally, West Pharmaceutical Servs forecasted revenue between $2.95B and $2.98B for the quarter.
Browse guidance and forecast on all stocks.
